India Based Indegene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Feb 04, 2021 By Alex Keown China’s JW Therapeutics, which was co-founded by Juno Therapeutics and Wuxi AppTec, forged a partnership with Thermo Fisher Scientific to ensure non-exclusive  commercial access to Thermo Fisher’s Gibco CTS Dynabeads CD3/CD28. The exclusive agreement will be used to support JW’s clinical development programs for CAR-T (Chimeric Antigen Receptor T-Cells) therapies in China. The deal includes JW Therapeutics’ lead product relmacabtagene  autoleucel (relma-cel), which is an anti-CD19 CAR-T therapy for third-line treatment for re...

Carlyle Group, Brighton Park Capital Invest $200M in Indian Health Tech Provider Indegene to Fuel Global Expansion What You Should Know: – The Carlyle Group and Brighton Park Capital invests $200M in Bangalore, India-based Indegene to accelerate company’s global expansion and consolidate its industry-leading position in healthtech solutions. – Founded in 1998 by five first-generation entrepreneurs, Indegene has emerged as the leading digital transformation partner to the global life sciences industry. With more than 3,000 employees across North America, Europe, China, Japan and India, I...